Amid worries that Chad Billingsley will miss the remainder of the season after leaving his August 24 start with an elbow injury the Dodgers right-hander got a platelet-rich plasma injection yesterday.
For now the team is calling Billingsley’s injury merely “inflammation,” but Ken Gurnick of MLB.com notes that “the PRP injection is generally used for tears in tendons and ligaments.”
Don Mattingly indicated to Gurnick that Billingsley will attempt to start a throwing program after receiving the injection and if it doesn’t go smoothly he’ll likely be shut down for the year.
Billingsley has had a very strong season, starting 25 games with a 3.55 ERA and 128/45 K/BB ratio in 150 innings, posting his best ERA since 2008 and his best K/BB ratio ever.
Former Angels outfielder Jabari Blash has signed a one-year deal with the Tohoku Rakuten Golden Eagles of Nippon Professional Baseball, the team announced Friday. Per the Japan Times, the deal is said to be worth around $1.06 million. Blash was released from his contract with the Angels at the end of November.
The 29-year-old outfielder has had a rough go of it in the majors, where he failed to duplicate the promising results he delivered in the minors. While he consistently batted above .250 with 20-30 home runs per season at the Double- and Triple-A level, he petered out in back-to-back gigs with the Padres and Angels and slumped toward a .103/.200/.128 finish across 45 PA for Anaheim in 2018.
The hope, of course, is that the environment in NPB will help him get a better handle on his issues at the plate — in a best case scenario, resulting in a full-scale transformation that could make him more marketable to MLB teams in the future. To that end, Blash expects to be utilized as a cleanup batter in the Eagles’ lineup and will focus on assisting the club as they make a run toward the Japan Series.